The Marijuana Policy Project promotes their drug as a substitute for opiate pain pills. Like the worst offenders in the opiate industry, the cannabis lobby follows an addiction-for-profit business model. Their master plan needs 80% of the demand to be met by 20% of the users. Science shows no evidence for using medical marijuana as a substitute for pain pills.
Governor David Ige of Hawaii wisely refused to cave to lobbyists, and he vetoed a measure that would have allowed medical marijuana to treat opiate addiction.
A large-scale, major study from Australia demonstrates that cannabis doesn’t work as a substitute for opiate pills in instances of chronic, non-cancer pain. The study came out in July, 2018 and it supports the findings of an American study published in September, 2017.
The three-year research study by Olfson, Wall et. al., Cannabis use and the Risk of Prescription Opioid Use Disorder, 2018, concluded: “Cannabis use appears to increase rather than decrease the risk of developing nonmedical prescription opioid use and opioid use disorder.” More than a year ago, Dr. Ken Finn, professional advisorto Parents Opposed to Pot, published Current Research on Marijuana in Pain is lacking.
It seems we should NOT be encouraging “medical” marijuana use if our goal is to stop addiction. Theodore Caputi and Keith Humphreys recently published in the Journal of Addiction: Medical marijuana users are more likely to use prescription drugs medically and nonmedically. They concluded: “Medical marijuana users should be a target population in efforts to combat nonmedical prescription drug use.” See our page on Marijuana vs. Pain Pills.
The Canadian Family Physicians wrote an editorial about Medical Marijuana in February, 2018, p. 87, after devoting an entire issue to the journal on medical marijuana. Like the NAS report in the United States, the Canadian physicians reviewed hundreds of relevant studies. In the editorial, they concluded:
“Evidence indicates the most consistent effects of medical cannabinoids are adverse events. A variety of adverse events have a greater magnitude of effect than the potential benefits for the conditions targeted.
Read the Clinical Conundrum of Medical Marijuana for more information. Dr. Ken Finn treats pain patients at of Springs Rehab in Colorado Springs. He advises that there are more than 600 drug interactions with medical marijuana. Are any medical marijuana dispensaries giving these warnings? Another Colorado doctor who advocates marijuana for pain recently stated that marijuana edibles and concentrates should be banned.
Just as digital transformation has disrupted legacy business models, cannabis legalization will fundamentally challenge workplace policies.
On Oct. 17, recreational marijuana will officially become legal in Canada. According to a recent study conducted by Deloitte, 22 per cent of the Canadian adult population consumes recreational cannabis at least occasionally, and a further 17 per cent show some willingness to try it.
When we look at the single largest generation in the work force – millennials born between 1980 and 2000 – we see even higher receptivity. A national millennial study conducted by Intercept revealed that nearly three-quarters of respondents agree with the legalization of cannabis. And, they’re eager to try a variety of formats, including marijuana-infused baked food (52 per cent), skin lotions (49 per cent), candy (40 per cent) and vapour (38 per cent). Interestingly, while the majority of millennials agree with legalization, they also have concerns. Nearly 40 per cent believe it may lead to poorer performance at work.
Like it or not, cannabis consumption is about to spike. The total number of Canadians who’ve already registered for medical marijuana use exceeded 270,000 in December, 2017, according to Health Canada.
If you’re concerned about the implication of cannabis legalization, you’re in good company. In a report by the Conference Board of Canada, more than half of Canadian employers expressed concern about the implications of legalized marijuana on the workplace.
Cannabis will force company leaders to rethink existing workplace policies and implement new ones to ensure they’re offering a safe, inclusive and productive environment.
Vaping can damage vital immune system cells and may be more harmful than previously thought, a study suggests.
Researchers found e-cigarette vapour disabled important immune cells in the lung and boosted inflammation. The researchers "caution against the widely held opinion that e-cigarettes are safe".
However, Public Health England advises they are much less harmful than smoking and people should not hesitate to use them as an aid to giving up cigarettes. The small experimental study, led by Prof David Thickett, at the University of Birmingham, is published online in the journal Thorax.
Research studies (see Stoové et al, 2009) have long associated surviving a drug overdose with the increased likelihood of a future non-fatal or fatal drug overdose. In a 2017 Massachusetts study of opioid overdoses, 10% of those who survived died within the next year from a drug overdose or other causes. In one of the most rigorous U.S. follow-up studies, Dr. Mark Olfson and colleagues compared the mortality rates of people who had survived a non-fatal opioid overdose to demographically matched members of the general U.S. population. They found that those who survived an opioid overdose died in the next year at 24 times the mortality rate of those in the general population, with most deaths attributed to drug-related diseases, subsequent overdose, circulatory disease, respiratory disease, cancer, HIV, viral hepatitis, and suicide. In another study that might be christened an investigation into lost opportunities, Dr. Linn Gjersing and colleagues found in a retrospective analysis of people who died of a drug overdose that 61% had previously sought emergency medical care and that 18% were frequent users of emergency medical services. The reasons for seeking past emergency care included somatic complaints (48%), injury (44%), alcohol and other drug-related medical problems (32%), and drug overdose (26%).
This is just one of the reasons why it is vital to divert drug users into recovery programs, not simply enable and equip them to continue self-harming with substances – These drug use endorsing mechanisms only increase the risk of harm that the same so-called ‘harm reduction’ strategies are supposed to lessen! (D.I. Comment)
Taking Action - Stopping Ice
United Nations Office of Drugs & Crime: Drug Prevention & Treatment
Medicinal Cannabis –
Access to medicinal Cannabis Products (TGA)
Access to medicinal cannabis products: steps to using access ...
Presentations, Statements & Conference Resources from WFAD 2018 Forum